在儿童心脏导管治疗期间,麻醉策略与心内血动力学之间的关系
Andrew H Smith1,2, Steven J Healan3, Genevieve E Staudt4
1Department of Pediatrics, Division of Pediatric Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Cardiology in the young
|September 1, 2025
概括
在心脏导管治疗期间,麻醉剂的选择对心脏病患者的血液动力学有显著影响. 中度镇静增加了肺/全身血流比,而静脉内全身麻醉影响了全身血管阻力.
科学领域:
- 儿童心脏病学
- 麻醉学
- 心血管生理学
背景情况:
- 患有心脏病的儿童在心脏导管时需要谨慎的血液动力管理.
- 麻醉的选择可以影响心血管参数,可能影响手术结果.
- 了解这些影响对于优化患者护理至关重要.
研究的目的:
- 在接受心脏导管治疗的儿科心脏病患者中研究不同麻醉选择的血液动力学影响.
- 将中度镇静与全身麻醉对关键血液动力学变量的影响进行比较.
- 分析吸入性挥发性麻醉与静脉内全身麻醉在特定儿科心脏手术中的影响.
主要方法:
- 第1项研究:对接受导管治疗的左心低质综合征婴儿的血液动力学数据进行二次分析,比较中度镇静和全身麻醉.
- 研究2:对接受管关闭手术或心脏移植活检的患者进行前性分析,比较吸入性挥发性麻醉和全静脉麻醉.
- 分析的血液动力学参数包括肺和全身血管阻力指数的身体表面积 (PVRi,SVRi) 和肺/全身血流 (Qp/ Qs).
主要成果:
- 在研究1中,适度镇静与Qp/ Qs> 1的几率增加了2倍,不论是分流类型,PVRi或患者大小.
- 在研究2中,与吸入性挥发性麻醉相比,全静脉麻醉导致SVRi显著增加.
- 在研究2小组中,全静脉麻醉 (PDA关闭) 增加了Qp/ Qs,全静脉麻醉 (心脏移植) 增加了左心室末端心压.
结论:
- 麻醉类型显著影响血液动力学参数,如SVRi,左心室末端透气压,以及儿童心脏导管时的Qp/ Qs.
- 基于这些患者的血液动力学数据的临床决策应考虑所选择的麻醉剂及其程序内管理.
- 仔细选择和管理麻醉对于准确的血液动力学评估和儿童心脏导管治疗的患者安全至关重要.
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
153
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193
Cardiac Catheterization III: Left Heart Catheterization
203
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
203
Cardiac Catheterization II: Right Heart Catheterization
162
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
162
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75


